Simpson Thacher represented First Advantage, while Davis Polk advised the representatives of the several underwriters in the offering. First Advantage announced the $345 million secondary offering of...
First Advantage’s $345 Million Shares Offering
TaskUs’ $766.9 Million Follow-on Offering
Davis Polk advised the representatives of the several underwriters in the offering. Simpson Thacher represented TaskUs. TaskUs, Inc. announced the upsized $766.9 million public offering of 12,077,480...
New Residential Investment’s Acquisition of Genesis Capital
Davis Polk advised Genesis Capital LLC and affiliates of Goldman Sachs on the transaction. New Residential Investment Corp. announced the acquisition of Genesis Capital and a related...
Nuvei’s $425 Million Initial Public Offering
Davis Polk advised Nuvei Corporation on the deal. Nuvei Corporation executed its initial U.S. public offering of 3,450,000 subordinate voting shares, including 450,000 subordinate voting shares...
Thoughtworks Holding’s $889.7 Million Initial Public Offering
Davis Polk advised representatives of the several underwriters in the offering. Thoughtworks Holding, Inc. executed the $889.7 million initial public offering of 42,368,421 shares of its common...
ChargePoint’s $282 Million Secondary Offering
Davis Polk advised the representatives of the several underwriters on the offering. The $282 million SEC-registered offering of 12,000,000 shares of common stock of ChargePoint Holdings,...
SOPHiA GENETICS’ $234 Million Initial Public Offering on Nasdaq
Homburger and Davis Polk advised SOPHiA GENETICS on the deal. Lenz & Staehelin acted as Swiss counsel to the underwriters. SOPHiA GENETICS SA listed its shares...
Century Therapeutics’ $242.7 Million Initial Public Offering
Davis Polk advised the representatives of the several underwriters in the offering. Century Therapeutics, Inc. executed the $242.7 million initial public offering of 12,132,500 shares of...
Codere Online’s Business Combination with DD3 Acquisition Corp. II
Davis Polk and Clifford Chance advised Codere on the deal, while Greenberg Traurig, Pérez Llorca and Stibbe advised DD3 Acquisition Corp. II. Willkie Farr & Gallagher...
Jamf’s $281 Million Stock Offering
Davis Polk advised the representatives of the several underwriters in the offering. The $281 million follow-on offering of 8,500,000 shares of common stock of Jamf Holding...
ImmunityBio’s $500 Million At-the-Market Offering
Davis Polk advised the sales agent on the offering. ImmunityBio, Inc. executed an at-the-market offering of its common stock for up to an aggregate amount of $500 million....
ImmunityBio’s $500 Million At-the-Market Offering
Davis Polk advised the sales agent on the offering. ImmunityBio, Inc. executed an at-the-market offering of its common stock for up to an aggregate amount of $500 million....